The Scientific Reporters

Exploring Science

The Scientific Reporters

Asymptomatic COVID-19 transmission is very rare says WHO: A myth or truth?

With COVID-19 showing no mercy, and the number of confirmed cases increasing around the world, it is important to find the truth behind the transmission of asymptomatic cases. As the number of COVID-19 cases rising every day, it is important…

Capture Myopathy: A leading cause of death in spotted deer and its solution

Capture myopathy is a non-infectious disease of the muscle, associated with capturing or handling any wild animals in which the muscle fibers do not function properly resulting in muscle weakness, muscle damage, muscle cramps, stiffness, and spasm can also be…

Respiratory failure during COVID-19 could be linked to certain genetic variants

Using data from genome-wide association study, experts speculate that gene variants encoding blood types and a multidisciplinary chromosome 3 could be the reason behind respiratory failure during COVID-19. Though it’s been several months since its first case, COVID-19 still manages…

Biotech Industry Marking a New Era Post-COVID-19

The inevitable need for a COVID-19 treatment has stirred up much-needed interest in Biotech industries all over the world. Here a straightforward take on Biotech industries post-COVID-19.  It is pretty astonishing how perceptions change in a short period of time….

Does the current COVID-19 pandemic resemble the 1918 Spanish flu?

With the number of COVID-19 increasing every day, and no treatment available, governments’ options are limited to social distancing and learning from the past. Here’s how COVID-19 resembles the 1918 Spanish Flu.  With several countries easing down the lockdown, concerns…

COVID19: AstraZeneca & Serum Institute of India collaborate to sign a deal for 1 billion doses of the novel Oxford University vaccine

The new Oxford University vaccine AZD 1222 shows promising results in COVID-19 patients. A deal signed by AstraZeneca and Serum Institute of India promises a billion doses of the vaccine for middle and low-income countries. With COVID-19 claiming its share…

COVID-19: Can a novel flu drug be the breakthrough we all need?

With certain COVID-19 symptoms resembling the common flu, experts wonder if a new anti-flu drug- Baloxavir may be the solution we have all been waiting for.  The entire world is currently battling against COVID-19, as the number of confirmed cases…

Premas biotech announced the completion of their vaccine prototype against COVID-19.

With the race against COVID-19 building tension among the healthcare sector, India based biotech company, Prema Biotech announces successful completion of their vaccine prototype against COVID-19 using inhouse D-crypt technology. With COVID-19 infecting millions and claiming over 300,00 lives all…

A much-needed discovery: Scientists find a way to infect mice with COVID-19

The novel COVID-19 though effective in spreading among humans is not capable of the same in mice. Being a go-to model for studying diseases and developing treatments, scientists find a way to use CRISPR/Cas9 to infect the mice with COVID-19…

Can Riboflavin & UV light reduce COVID-19 pathogens in blood?

The recent outbreak of the novel virus COVID-19 has been termed a pandemic by the WHO. Although the disease is known to spread from person to person through air droplets, the virus still manages to surprise scientists every day. New…